Placement on COVID-19 Units Does Not Increase Seroconversion Rate of Pediatric Graduate Medical Residents

dc.contributor.authorCrisci, Timothy
dc.contributor.authorArregui, Samuel
dc.contributor.authorCanas, Jorge
dc.contributor.authorHooks, Jenaya
dc.contributor.authorChan, Melvin
dc.contributor.authorPowers, Cory
dc.contributor.authorSchwaderer, Andrew L.
dc.contributor.authorHains, David S.
dc.contributor.authorStarr, Michelle C.
dc.contributor.departmentPediatrics, School of Medicine
dc.date.accessioned2024-03-26T08:24:09Z
dc.date.available2024-03-26T08:24:09Z
dc.date.issued2021-04-29
dc.description.abstractBackground: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease COVID-19 (coronavirus disease 2019) has presented graduate medical education (GME) training programs with a unique set of challenges. One of the most pressing is how should hospital systems that rely on graduate medical residents provide appropriate care for patients while protecting trainees. This question is of particular concern as healthcare workers are at high risk of SARS-CoV-2 exposure. Objective: This cross-sectional study sought to assess the impact of hospital COVID-19 patient placement on pediatric graduate medical residents by comparing rates of SARS-CoV-2 seroconversion rates of residents who worked on designated COVID-19 teams and those who did not. Methods: Forty-four pediatric and medicine–pediatric residents at Riley Children's Hospital (Indianapolis, IN) were tested for SARS-CoV-2 immunoglobulin M (IgM) and IgG seroconversion in May 2020 using enzyme-linked immunosorbent assays (Abnova catalog no. KA5826), 2 months after the first known COVID-19 case in Indiana. These residents were divided into two groups: those residents who worked on designated COVID-19 teams, and those who did not. Groups were compared using χ2 or Fisher exact test for categorical variables, and continuous variables were compared using Student t testing. Results: Forty-four of 104 eligible residents participated in this study. Despite high rates of seroconversion, there was no difference in the risk of SARS-CoV-2 seroconversion between residents who worked on designated COVID-19 teams (26% or 8/31) and those who did not (31% or 4/13). Eleven of 44 residents (25%) tested positive for SARS-CoV-2 IgG, whereas only 5/44 (11.4%) tested positive for SARS-CoV-2 IgM, without a detectable difference between exposure groups. Conclusion: We did not observe a difference in SARS-CoV-2 seroconversion between different exposure groups. These data are consistent with growing evidence supporting the efficacy of personal protective equipment. Further population-based research on the role of children in transmitting the SARS-CoV-2 virus is needed to allow for a more evidence-based approach toward managing the COVID-19 pandemic.
dc.eprint.versionFinal published version
dc.identifier.citationCrisci T, Arregui S, Canas J, et al. Placement on COVID-19 Units Does Not Increase Seroconversion Rate of Pediatric Graduate Medical Residents. Front Pediatr. 2021;9:633082. Published 2021 Apr 29. doi:10.3389/fped.2021.633082
dc.identifier.urihttps://hdl.handle.net/1805/39497
dc.language.isoen_US
dc.publisherFrontiers Media
dc.relation.isversionof10.3389/fped.2021.633082
dc.relation.journalFrontiers in Pediatrics
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePMC
dc.subjectCoronavirus disease 2019
dc.subjectGraduate medical education
dc.subjectNosocomial spread
dc.subjectSevere acute respiratory syndrome coronavirus 2
dc.subjectTransmission
dc.titlePlacement on COVID-19 Units Does Not Increase Seroconversion Rate of Pediatric Graduate Medical Residents
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Crisci2021Placement-CCBY.pdf
Size:
522.65 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: